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background: In patients with drug resistant hypertension (RHTN) renal sympathetic denervation (RDN) based on single tip electrode catheter 
significantly reduced office blood pressure (BP) some weeks or months after the procedure while multi-systems resulted in a earlier effect at 1 
month post procedure. The aim of the study was to investigate the effects of RDN on office and ambulatory BP levels at 1 and 2 weeks after the 
procedure in drug RHTN patients.
methods: Nineteen patients with drug RHTN (age: 58±9 years, 12 males, office BP: 180/96±19/16 mmHg, 24-hour BP: 151/85±16/14 mmHg, 
daytime BP: 155/88±17/15 mmHg and nighttime BP: 142/79±14/13 mmHg, under 4.4±0.6 drugs) underwent RDN with the use of the EnligHTN 
multi-electrode ablation catheter (St. Jude Medical, CA, USA). In all participants office BP measurements and ambulatory BP recordings over a 
working day according to established methodology were performed at baseline as well as at 1 and 2 weeks after RDN. There were no alterations in 
antihypertensive therapy during this period of 2 weeks follow-up.
results: Office BP decreased by -27/9±16/8 mmHg at 1 week and by -31/11±18/8 mmHg at 2 weeks compared to baseline (p<0.001 for both). 
In the 2 post-procedural time points 15 patients were consistently office BP responders defined as those with a systolic BP decrease of at least 10 
mmHg. There was also a sustained significant reduction in 24-hour ambulatory BP by -16/9±9/7 mmHg at 1 week and by -16/7±12/8 mmHg at 2 
weeks (p<0.001 for both). Furthermore, daytime BP was decreased by -18/10±11/9 mmHg at 1 week and by -17/8±11/8 mmHg at 2 weeks, while 
nighttime BP was also reduced by -12/6±11/5 mmHg and -13/6±11/6 mmHg at 1 and 2 weeks respectively (p<0.001 for all).
conclusions: In drug RHTN patients RDN by using the multi-electrode EnligHTN system achieved an early and substantial reduction of office 
and ambulatory BP parameters at 1 and 2 weeks after the procedure. These results underscore the efficacy of catheter-based RDN in favorable BP 
modulation and provide evidence for the time pattern of RDN-induced changes on hemodynamic load in resistant hypertension.
